26 Jun 2013 14:47
RNS Number : 9347H
Silence Therapeutics PLC
26 June 2013
RESULT OF AGM
26 June 2013
At the Company's annual general meeting held this morning all resolutions were passed, except for the re-appointment of David Mack as director, which was withdrawn following his resignation.
For further information please contact:
Silence Therapeutics
Ali Mortazavi, chief executive/Timothy Freeborn, finance director +44 (0)333 988 0140
a.mortazavi@silence-therapeutics.com
t.freeborn@silence-therapeutics.com
N+1 Singer
Shaun Dobson/Jenny Wyllie
+44 20 7496 3000
shaun.dobson@n1singer.com
jenny.wyllie@n1singer.com
This information is provided by RNS
The company news service from the London Stock Exchange
SLN.L (SLN)